There was a significant trend of decreased monocyte-endothelial adhesion observed in TGF-β inhibitor groups compared to groups treated with G6PD inhibitors alone ( Figure 3 E).
← all excerpts
Glucose-6-Phosphate Dehydrogenase Deficiency Activates Endothelial Cell and Leukocyte Adhesion Mediated via the TGFβ/NADPH Oxidases/ROS Signaling Pathway.
1
—
—